Press ReleaseTechJia Xudong, partner of Fintopia, emphasized the importance of three dimensions for financial technology to go global BEIJING, May 24, 2024 /PRNewswire/ — A news report from ifeng.com: Recently,… CISION PRNewswireMay 24, 2024
Press ReleaseASCO 2024 | Ascentage Pharma Releases Latest Results from Multiple Clinical Studies of Its Lead Drug Candidates SUZHOU, China and ROCKVILLE, Md., May 24, 2024 /PRNewswire/ — Ascentage Pharma (6855.HK), a global… CISION PRNewswireMay 24, 2024
Press ReleaseBusting fear barrier about hormone replacement therapy in new era of menopause management MANILA, Philippines, May 24, 2024 /PRNewswire/ — Millions of women around the… CISION PRNewswireMay 24, 2024
Press ReleaseAntengene To Present One Oral and Four Abstracts at ASCO 2024 Oral Presentation：a Phase II study of ATG-008 (mTORC1/2 Inhibitor) combined with PD-1… CISION PRNewswireMay 24, 2024
Press ReleaseTranscenta Debuts Encouraging Phase II Data from First-line Triple Combo Trial of Osemitamab (TST001) for G/GEJ Cancer at ASCO 2024 Phase II results reveal median PFS of 12.6 months in patients with… CISION PRNewswireMay 24, 2024
Press ReleaseHeadwolf Tablets Make a Grand Entrance into the Korean Market with Four New Models SEOUL, South Korea, May 24, 2024 /PRNewswire/ — Headwolf is set to… CISION PRNewswireMay 24, 2024
Press ReleaseCNOOC Limited Subsidiaries Signed EPCCs with MIREME and ENH HONG KONG, May 24, 2024 /PRNewswire/ — CNOOC Limited (the "Company", SEHK:… CISION PRNewswireMay 24, 2024
Press ReleaseTranscenta Debuts Encouraging Phase II Data from First-line Triple Combo Trial of Osemitamab (TST001) for G/GEJ Cancer at ASCO 2024 Phase II results reveal median PFS of 12.6 months in patients with… CISION PRNewswireMay 24, 2024
